Question: Please read and follow the attachment. It's including a sample of Conference call summery as well. My conference call link is http://services.choruscall.com/links/hlt160427h2d9rk6z Pleae use the

Please read and follow the attachment. It's including a sample of Conference call summery as well.
My conference call link is http://services.choruscall.com/links/hlt160427h2d9rk6z
Pleae use the format from the attachiment and make in APA Style. *NO PDF
If you have a question, let me know. Thank you.

Conference Call Assignment Financial Statement Analysis Objective: The purpose of this assignment is to help you to understand the value of reviewing the most recent conference call in analyzing your target company and preparing your Research Report. You will prepare a one page analysis of the appropriate conference call for the company that you have chosen. Instructions: 1. Access the appropriate conference call for the most recent quarterly earnings release (links are on the last page of this document - Page 4). 2. As you listen to the call take notes that will help you fill in the 1 page Conference Call summary - No more than 1 page! 3. Fill out the one page Summary (following page - Page 2): a. Save only that page with your name on it (Delete the other 3 pages) b. Submit it through the appropriate Drop Box. 4. Use the Example on the third page to help guide you in completing this report. Page - 1 Conference Call Summary Your Name Here Company (Symbol) Period Reported Quarter / Ending: Total Period: Revenue for the period Quarter: Total Period: EPS for the period Quarter: Total Period: Management Participants /Title CEO CFO Other Other Highlights (3 or 4) Financial Guidance Questions and Responses (2 or 3) Revenue / Period Earnings or EPS Other Q1: R1: Q2: R2: Q3: R3: Analytical Outlook Page - 2 Company (Symbol) Conference Call Summary Example: http://www.earningscast.com/TMO/20130424 Thermo Fisher Scientific (TMO) Period Reported Revenue for the period Quarter / Ending: Q3 / 9/29/12 Quarter: $3.1 Bil Total Period: $9.3 Bil EPS for the period Quarter: $0.79 Total Period: $2.19 Management Participants /Title CEO Marc Casper CFO Pete Wilver Other Other EPS growth of 29% (adjusted) Strong growth in China - New plant to open next month Several new monitoring instruments i.e., in pharmaceuticals Closed acquisition of One Lambda Revenue / Period $12.3 - $12.4 Bil FY 2012 (12/31) Earnings or EPS EPS (adjusted) $4.81 - $4.88 Other CAPX - $300 mil Q1: How is Lab R1: Positive on overall outlook Products and Services Going? Highlights (3 or 4) Financial Guidance Questions and Responses (2 or 3) Q2: 2013 Free cash flow outlook and use of capital Q3: Expectations for One Lambda in 2013 Analytical Outlook Total Period: 9 mo. R2: Buybacks will continue. Will repay some debt. R3: Contribution of $0.09 - 0.11 EPS in 2013 The overall growth seems good for the last quarter and full year 2013. New initiatives such as global sourcing should help lower costs. Life sciences areas are doing particularly well. One Lambda acquisition will become increasingly important to the company. Management's overall outlook is for good growth in revenue and earnings. Page - 3 The links above are for the most recent conference calls available as of the second week of May 2016. Some companies may have more recent conference calls. It is your responsibility to check to see if there are more recent calls and to substitute those calls, if available. Page - 4
Step by Step Solution
There are 3 Steps involved in it
Get step-by-step solutions from verified subject matter experts
